A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
Jain, Aditi, Vispute, Abhay, Dange, Amol, Naskar, Arindam, Mondal, Asish, Vivekanand, B., Sharma, Balram, Varade, Deepak, Shukla, Dhaiwat, Bhatia, Girish, Chaudhari, Harshal, Ram Babu, K., Gavali, Onkar, Sorate, Sanket, Bhanushali, Shaishav, Kothari, Vaibhav, Khandelwal, Vipul, Sharma, Akhilesh, Pawar, Roshan, Mayabhate, Mayur, Shahavi, Vinayaka, Rajput, Aashishsingh, Jaiswal, Mukesh
Published in Diabetes therapy (01.01.2024)
Published in Diabetes therapy (01.01.2024)
Get full text
Journal Article